Product Images Nabumetone

The text seems to describe a medication called Nabumetone, which comes in 750mg tablets and is used for RELAFEN #60. It warns that the medication may cause dizziness or drowsiness and advises to avoid alcohol. It is recommended to take with food. The last line is not-readable.*

This text suggests some common symptoms associated with potential health issues, particularly related to breathing difficulties, speech problems, chest pain, swelling of the face or throat, and weakness in one part or side of your body. If you are experiencing any of these symptoms, you should seek medical attention immediately.*

This is a list of different forms of metabolites found after administering nabumetone. These include unchanged nabumetone and its metabolites such as 6MNA, 6HNA, and 0-desmethyl-nabumetone in both conjugated and unconjugated forms. There is also a minor amount of unidentified metabolites. The percentages represent the total amount of each metabolite detected and range from not detectable to 73%.*

COOH and CH40 are not available in English. 6-methoxy-2-naphthylacetic acid (6MNA) is an organic compound that belongs to the class of naphthalenes. It is used as a non-steroidal anti-inflammatory drug (NSAID).*

This text describes various symptoms that could indicate different health conditions. Nausea, fatigue, weakness, itching, stomach pain and flu-like symptoms can be caused by multiple ailments, including viral infections or food poisoning. However, if skin or eyes turn yellow, it could be a sign of liver problems. Vomiting blood or finding blood in bowel movements could indicate bleeding in the digestive system. Unusual weight gain, skin rashes or blisters with fever and swelling of the arms, legs, hands, and feet requires medical attention for proper diagnosis and treatment.*

This is a list of nonsteroidal anti-inflammatory drugs (NSAIDs) that are commonly used to treat pain and inflammation. It includes generic names and their associated brand names. These include celecoxib (Celebrex), diclofenac (Cataflam, Voltaren, Arthrotec), diflunisal (Dolobid), etodolac (Lodine, Lodine XL), fenoprofen (Nalfon, Nalfon 200), flurbiprofen (Ansaid), ibuprofen (Motrin, Tab-Profen, Vicoprofen, Combunox), indomethacin (Indocin, Indocin SR, Indo-Lemmon, Indomethagan), ketoprofen (Oruvail), ketorolac (Toradol), mefenamic acid (Ponstel), meloxicam (Mobic), nabumetone (Relafen), naproxen (Naprosyn, Anaprox, Anaprox DS, EC-Naproxyn, Naprelan, Naprapac), oxaprozin (Daypro), piroxicam (Feldene), sulindac (Clinoril), and tolmetin (Tolectin, Tolectin DS, Tolectin 600).*

This is a description of the serious side effects and other common side effects associated with a certain medication. It lists life-threatening conditions such as heart attack, stroke, and allergic reactions as well as less serious but common symptoms such as stomach pain, constipation, and dizziness.*

This is a graph that shows the plasma concentration of Nabumetone Active Metabolite (6MNA) at steady state following once-daily dosing of Nabumetone. The x-axis represents time in hours while the y-axis represents concentration in meg/mL. The graph shows the concentration for two doses: 1000mg and 2000mg. There were 31 people in the 1000mg group and 12 people in the 2000mg group. The concentration peaked at around 15 hours and gradually decreased over time.*

This appears to be a chemical formula and information about a molecule. The molecule has a molecular weight of 228.3 grams per mole and consists of the elements carbon, hydrogen, and oxygen. It is likely a organic compound with the molecular formula of C15H1602. The abbreviation "CHg" is not a well-recognized chemical symbol, so it may be an error or an unusual abbreviation.*

This is a table containing information on the mean and standard deviation of various parameters for administering a substance in different doses to young adults and elderly individuals. The abbreviation for the substance is not given, and the units of measurement for the parameters are also unknown. The number of participants in each group is provided. The parameters listed include T, ty, CLgg/F, and Vdg/F.*

This table shows the Mean/Mode Duration of different doses of Nabumetone for patients with RA. The table also shows the number of patients receiving each treatment for a duration of years.*